Belgian biotechnology company Devgen NV (DEVG.BT) Friday said it has recieved EUR20 million from Monsanto Co. (MON) in a revision of their 2007 cooperation pact.

Monsanto now has broader rights to Devgen technology. In exchange, Devgen receives EUR20 million in cash. Additional details of the agreement were not disclosed.

Company Web site: http://www.devgen.com